Voyager Therapeutics Inc (VYGR)

Finanzdaten der Voyager Therapeutics Inc-Aktie (VYGR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	22.06%3.17	2.59	15.34	13.37	5.20
	10.06%29.56	32.86	45.27	43.96	41.83
Research and Development	10.41%22.04	24.60	35.95	35.87	31.33
Operating Income/Loss	12.81%-26.39	-30.27	-29.93	-30.59	-36.63
Nonoperating Income/Loss	17.38%1.94	2.35	2.52	2.79	3.26
Income/Loss From Continuing Operations Before Tax	12.43%-24.45	-27.92	-27.42	-27.81	-33.37
Income Tax Expense/Benefit	42.86%0.02	0.01	0.01	0.08	0.02
	12.40%-24.47	-27.94	-27.43	-27.89	-33.38
Attributable To Parent	12.40%-24.47	-27.94	-27.43	-27.89	-33.38
Basic Average Shares	1.77%60.55	59.50	0.08	58.80	58.67
Diluted Average Shares	1.77%60.55	59.50	0.08	58.80	58.67
Basic Earnings Per Share	14.89%-0.40	-0.47	-0.47	-0.47	-0.57
Diluted Earnings Per Share	14.89%-0.40	-0.47	-0.47	-0.47	-0.57